MECHANISTIC PBPK MODELING OF CREATININE-DRUG INTERACTIONS IN CHRONIC KIDNEY DISEASE POPULATION.

被引：0
|
作者：
Takita, H. [1 ,2 ]
Scotcher, D. [2 ]
Chinnadurai, R. [3 ]
Kalra, P. [3 ]
Galetin, A. [2 ]
机构：
[1] Asahi Kasei Pharma, Shizuoka, Japan
[2] Univ Manchester, Manchester, Lancs, England
[3] Salford Royal NHS Fdn Trust, Salford, Lancs, England
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-053
引用
收藏
页码：S59 / S60
页数：2
相关论文
共 50 条
  • [31] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Duan, Peng
    Zhao, Ping
    Zhang, Lei
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (04) : 689 - 705
  • [32] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Peng Duan
    Ping Zhao
    Lei Zhang
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 689 - 705
  • [33] Potential food-drug interactions in a VA nursing home population.
    Lisi, DM
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S98 - S98
  • [34] PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF DISPOSITION AND DRUG-DRUG INTERACTIONS FOR VALPROIC ACID/DIVALPROEX
    Reed, R.
    Conner, T.
    Zhang, T.
    [J]. EPILEPSIA, 2017, 58 : S158 - S159
  • [35] Docetaxel, cyclophosphamide, and epirubicin: application of PBPK modeling to gain new insights for drug-drug interactions
    Li, Tongtong
    Zhou, Sufeng
    Wang, Lu
    Zhao, Tangping
    Wang, Jue
    Shao, Feng
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2024, 51 (04) : 367 - 384
  • [36] Illicit drug use, hypertension, and chronic kidney disease in the US adult population
    Akkina, Sanjeev K.
    Ricardo, Ana C.
    Patel, Amishi
    Das, Arjun
    Bazzano, Lydia A.
    Brecklin, Carolyn
    Fischer, Michael J.
    Lash, James P.
    [J]. TRANSLATIONAL RESEARCH, 2012, 160 (06) : 391 - 398
  • [37] Chronic Kidney Disease and Stroke Outcomes: Beyond Serum Creatinine
    Bruce, Samuel S.
    Parikh, Neal S.
    [J]. STROKE, 2023, 54 (05) : 1278 - 1279
  • [38] Correlation of Ultrasonographic Parameters with Serum Creatinine in Chronic Kidney Disease
    Siddappa, Jagdeesh K.
    Singla, Saurabh
    Al Ameen, Mohammed
    Rakshith, S. C.
    Kumar, Naveen
    [J]. JOURNAL OF CLINICAL IMAGING SCIENCE, 2013, 3
  • [39] Rare mutations associating with serum creatinine and chronic kidney disease
    Sveinbjornsson, Gardar
    Mikaelsdottir, Evgenia
    Palsson, Runolfur
    Indridason, Olafur S.
    Holm, Hilma
    Jonasdottir, Aslaug
    Helgason, Agnar
    Sigurdsson, Snaevar
    Jonasdottir, Adalbjorg
    Sigurdsson, Asgeir
    Eyjolfsson, Gudmundur Ingi
    Sigurdardottir, Olof
    Magnusson, Olafur Th
    Kong, Augustine
    Masson, Gisli
    Sulem, Patrick
    Olafsson, Isleifur
    Thorsteinsdottir, Unnur
    Gudbjartsson, Daniel F.
    Stefansson, Kari
    [J]. HUMAN MOLECULAR GENETICS, 2014, 23 (25) : 6935 - 6943
  • [40] Effect of Pemafibrate on Serum Creatinine in Patients with Chronic Kidney Disease
    Imai, Enyu
    Imai, Atsuhiro
    [J]. JMA JOURNAL, 2022, 5 (03): : 328 - 333
12345